Navigation Links
$6.37 million from National Institutes of Health to find new ways to treat psoriasis
Date:11/6/2007

The National Institute of Arthritis and Musculoskeletal Skin Diseases (NIAMS), a research center at the National Institutes of Health (NIH), has awarded Case Western Reserve University School of Medicine and University Hospitals Case Medical Center a $6.37 million award to establish a Center of Research Translation (CORT) for the skin disease psoriasis.

This is one of the largest grants ever given to a medical institution in the United States for the study of psoriasis.

With a five-year grant from NIAMS, the Psoriasis CORT will bring a multidisciplinary team of translational physicians scientists, nurses, community clinicians, laity and basic scientists from different departments and disciplines together. This team will apply the intellectual and scientific resources of their institutions to new therapies to provide relief to patients with the skin disease that has long-term health and psychosocial consequences.

Our goal is to find ways to rebalance the human bodys immune system and skin cells to restrain the expression of this skin disease, said Kevin Cooper, M.D., department chair of dermatology at University Hospitals Case Medical Center (UHCMC) and professor of dermatology at the Case Western Reserve University School of Medicine. It is very important to obtain safe and durable remissions from disease because psoriasis has significant impact on patient health, spanning psychosocial effects, and risk for long-term cardiovascular complications and cancers.

The CORT grant complements a $5 million gift to University Hospitals Case Medical Center (UHCMC) from The Murdough Foundation that was received in December 2006 designed to advance the research and treatment of psoriasis. The gift remains the largest known in the United States for dermatology at an academic medical center. The Murdough Family Center for Psoriasis supports and stimulates clinical research and treatment for, and education about, psoriasis and creat
'/>"/>

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...e/ -- Welcome to syngo® .plaza(1), th... from Siemens Healthcare. As the first Pictu...om Siemens where 2D, 3D, and 4D reading come toget...hange the way multimodality images are read today....h Scientific Assembly and Annual Meeting of the Ra...
(Date:11/27/2009)...ewswire-FirstCall/ -- GSI Group Inc. (Pink Sheets:...chnology products and semiconductor systems, today... shareholders has been scheduled for Friday, April...ill be announced in due course. As previously ann...from Stephen Bershad, a holder of greater than ten...
(Date:11/27/2009)...ewswire-USNewswire/ -- Preventing disease is the g...every year, new vaccines are being added to assist...immunity for the same period of time? And, if not,...p immunity strong? ,, In this month,s issue o...of Pediatrics, Michael Pichichero MD, Director of ...
(Date:11/27/2009)...cal, economic burdens, study predicts , ,...f people with diabetes in the United States is exp...y predicts. , That would bring the total by 203...p from 23.7 million today. , , At the same time,...iple, the study also warns, rising from an estimat...
(Date:11/27/2009)...active anatomy education apps from Modality and Li...nces learning opportunities for iPhone and iPod to...November 27, 2009 -- Modality, Inc. and Lippinco...ters Kluwer Health, today announced the availabili...Store. Clemente’s Anatomy, Rohen’s Pho...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...t to interferon beta treatments , WEDNESDAY, Jan. ...xplain why some multiple sclerosis (MS) patients r...n international study. , Starting with 206 souther... reduced by interferon beta therapy to the DNA of ...
... Center New Orleans has been selected as the inaug...William J. Gies Award for Outstanding Innovation. ...tion at a black-tie celebration on March 29, 2008 .... Gies, a pioneer in dental education, the William...
...ements in key genes connected to the p53 regulator...y creating additional safeguards in human genes to...amage that could cause cancer or a variety of gene...l Academy of Sciences. Because genetically engine...
...hicago are still being exposed to chemicals banned.... The chemicals do not appear to be affecting the ...gs appear in the current issue of the Journal of G...e Illinois Natural History Survey, said that chemi...
... by Reverend Carlton W. Veazey, President and CEO ...:, "On the 35th anniversary of Roe v. Wade, our c...t that abortion will be safe, legal, and available...g promoted in at least 17 states are sounding the ...
...l Costs, WILMINGTON, Del., Jan. 16 Bollig & Kemp...pean auto industry, has signed,a license agreement...logy,that enables auto manufacturers to realize su...acture and sell water-based basecoats for use in t...
Other Medicine News:Health News:DNA Analysis Could Help Customize Treatments for MS 2Health News:LSUHSC dental school to be awarded top national honor 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 3Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 4Health News:Herons persist in Chicago wetlands despite exposure to banned chemicals 2Health News:Herons persist in Chicago wetlands despite exposure to banned chemicals 3Health News:Statement of the Reverend Carlton W. Veazey, President and CEO of the Religious Coalition for Reproductive Choice, on the 35th Anniversary of Roe v. Wade 2Health News:DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker 2
(Date:11/25/2009)...25 Reportlinker.com announces that...catalogue: ,, United States Dental Devices Mar...www.reportlinker.com/p0158733/United-States-Dental...l ,, United States Dental Devices Market Analy...is report is an essential source for in-depth info...
(Date:11/25/2009)...v. 25 Abaxis, Inc. (Nasd...ing point-of-care blood analysis systems, announce...ecutive officer, will present at the 21st Annual P...December 2, 2009 at 2:00 p.m. ET. The conference w...rk City. ,, About Abaxis ,, Abaxis develo...
(Date:11/25/2009)... Nov. 25 According to Millennium R...al technology market intelligence, the nearly $3 b...continue to see rapid growth over the next five ye...S Markets for Trauma Devices 2010 report finds ...he next five years, with competitors introducing s...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Rece 5591 1Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Rece 5591 2Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Rece 5591 3Data Analysis Reinforces the Safety Profile of Levemir 28R 29 5588 1Data Analysis Reinforces the Safety Profile of Levemir 28R 29 5588 2Data Analysis Reinforces the Safety Profile of Levemir 28R 29 5588 3Data Analysis Reinforces the Safety Profile of Levemir 28R 29 5588 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 1Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 17
...ce for unique Ranexa(R) mechanism of action -, CH...VTX ) announced today that ranolazine significantl...nts with a hereditary form of long QT,syndrome cal... the late,sodium channel and can be associated wit...anolazine also shortened cardiac relaxation time i...
...y re-evaluates this important question with today,...GO, March 30 Percutaneous coronary intervention,(...ed balloons and stents,to open a completely blocke...art -- is the best treatment for heart attack when...t the 90-minute treatment goal unless they,have a ...
Other Medicine Technology:Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 2Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 3Is PCI Safe, Effective After Clot-Busters for Heart Attack? 2Is PCI Safe, Effective After Clot-Busters for Heart Attack? 3
Malis Needle Holders
Vascular Clamps RD-S
Vascular Clamps B-1
Micro Emulsifying Needles
Medicine Products: